uMed Recruit

The digital patient recruitment platform that enrols patients for trials in days, not years.

What We Do

  • More patients

  • Faster enrolment

  • Greater diversity

Meet your recruitment target on time, every time

We increase monthly patients randomised by an average of 3x, empowering you to better meet your recruitment timeframe.

Minimise screening

We automatically pre-screen patients with EHR information and digital questionnaires so that ~80% of patients referred to sites by uMed go on to be randomised.

Increase population

We can identify and tailor our outreach towards ethnic minorities, achieving up to 5x more representation of minoritised groups.

Access novel
patient populations

We identify patients via primary care that are interested in clinical research but overlooked by traditional recruitment methods.

“Trial sites saw a rapid increase when using uMed to find and contact patients, versus them recruiting patients manually.”

Closed Loop Medicine

Why we're different

Integration with top 2 GP EHR software platforms

The only platform to integrate with a network of over 450 primary care practices which facilitates easy GP approval to reach out to patients.

EHR & hospitalisation data linkage

uMed can augment GP EHR data with secondary care HES data into a complete study data set, which would otherwise require manual collection.

Automatic patient outreach on behalf of recognised GP

The only platform to automatically reach out to approved patients via an SMS on behalf of their recognised GP.

How we work

We find the right patients from the start

Using health record data we are able to filter by specific inclusion and exclusion criteria, generating only the most relevant patient cohorts, therefore reducing screening failures at the site.

Additional screening

Patients complete a screening questionnaire based on the inclusion/exclusion criteria for the trial. Criteria that can’t be screened via questionnaire is screened and validated via phone by a registered nurse

Automatically engage potential trial participants

Once a potential trial participant is approved by our provider partner, we automatically reach out to the patient via SMS, email and/or letter to invite them to participate. The patient can find all the information on the study and consent electronically to be contacted by the trial site.

Workload for the provider practice is minimal

Therefore the full process, from initial patient identification to engagement, is extremely quick and efficient.

We’ve seen a significant increase and speed in enrolment each month since working with uMed, which is enabling our research to progress at a pace we never expected to achieve

Dr Alistair Noyce

Consultant Neurologist & Researcher at QMUL